Sweden· SE-20240115000142
Nemluvio 30 mg Pulver och vätska till injektionsvätska, lösning i förfylld injektionspenna
A medicinal product containing nemolizumab, registered in Sweden by Galderma International.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Nemolizumab
- Manufacturer
- Galderma International
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20240115000142
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nemolizumab in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumNemluvio 30 mgGalderma International
- IcelandNemluvioGalderma International
- PolandNemluvioGalderma International
- United KingdomNemluvio 30mg powder and solvent for solution for injection pre-filled pensGalderma (UK) Ltd
- NorwayNemluvioGalderma International
- SwitzerlandNemluvio 30 mg, Pulver und Lösungsmittel für Injektionslösung im FertigpenGalderma SA
- SpainNEMLUVIO 30 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EN PLUMA PRECARGADAGalderma International
- CzechiaNEMLUVIOGalderma International, La Défense
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Nemluvio
- Liechtenstein · Nemluvio
- Norway · Nemluvio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9fed8605-1e2d-4aff-aa3d-2ce581c187a2 GET /v1/drugs/9fed8605-1e2d-4aff-aa3d-2ce581c187a2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20240115000142",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20240115000142",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/nemluvio-epar-product-information_sv.pdf"
}See everything about nemolizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.